WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)
Malaria infection during pregnancy is a major public health problem, with substantial risks for the mother, her fetus and the newborn. In areas with moderate to high transmission of Plasmodium falciparum, the World Health Organization (WHO) recommends a package of interventions for controlling malaria and its effects during pregnancy, which includes the promotion and use of insecticide-treated nets (ITNs), the administration during pregnancy of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP), and appropriate case management through prompt and effective treatment of malaria in pregnant women.
Capacity building, Policy, Quality Assurance, Use
- Sub-categories Malaria
- Commodities Medicines, Mosquito nets, Vaccines
- Latest update April 2013
- Version
- Developed by WHO/OMS
- When to use Malaria infection during pregnancy is a major public health problem, with substantial risks for the mother, her fetus and the newborn. In areas with moderate to high transmission of Plasmodium falciparum, the World Health Organization (WHO) recommends a package of interventions for controlling malaria and its effects during pregnancy, which includes the promotion and use of insecticide-treated nets (ITNs), the administration during pregnancy of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP), and appropriate case management through prompt and effective treatment of malaria in pregnant women.
- Languages English
- Level of use Central, Regional
- Form pdf document
- Amount of training / TA required n/a
- Inputs & outputs n/a
- Cost free
- Advantages n/a
- Limitations n/a
- Availability http://www.who.int/entity/malaria/publications/atoz/Policy_brief_IPTp-SP_implementation_11april2013.pdf.pdf
- Remarks
- Contact Silvia Schwarte, WHO (schwartes@who.int)
- Submission date 2013-05-21 18:44:13